Composition for treating gallinaceous vibrio hepatitis and preparation method thereof

Abstract

The invention discloses a composition for treating gallinaceous vibrio hepatitis and a preparation method thereof, which aims at providing a composition capable of treating gallinaceous vibrio hepatitis infection, reducing germ medicine resisting probability, treating both principal and secondary aspects of diseases and preventing other bacterial secondary infection; and the invention also discloses a preparation method of the composition. The composition for treating gallinaceous vibrio hepatitis comprises the following components by weight percent: 5-20 percent of sulfamonomethoxine sodium,2-15 percent of mequindox, 1-4 percent of trimethoprim lactate, 1-10 percent of glucurolactone, 2-10 percent of taurine and the balance of anhydrous dextrose. The composition for treating gallinaceousvibrio hepatitis combines the sulfamonomethoxine sodium and the mequindox, effectively kills gallinaceous vibrio hepatitis pathogeny, i.e. an empty intestine campylobacter, reduces medicine resistingprobability and has a stronger inhabiting or killing function. The trimethoprim lactate enhances an antibacterial action of the sulfamonomethoxine sodium and has better treatment effect; the glucurolactone can detoxify, increase glycogen and reduce fat storage; and the taurine has the functions of inflammation resistance, refrigeration and liver and gall enhancement.

Description

technical field [0001] The invention relates to a composition for treating vibrio hepatitis in chickens and a preparation method thereof. Background technique [0002] Chicken vibrio hepatitis is also called chicken Campylobacter hepatitis. The pathogen is Campylobacter jejuni. The disease course is slow and the incidence is high. It can reduce egg production by 25-35%. Young chickens may delay egg production or low egg production. , the most obvious case change is hepatitis or hepatic necrosis. Although the mortality rate of this disease is low, it is easy to cause the body's resistance to decline, and it is easy to cause secondary infections such as E. coli and Salmonella, and cause death. [0003] Now the disease is more difficult to treat, and common drugs are used. While killing the pathogen, they often have no therapeutic effect on hepatitis. Similarly, they cannot kill the pathogen while treating hepatitis. Advanced antibacterial drugs cannot control the disease well...

AI Technical Summary

Problems solved by technology

[0002] Chicken vibrio hepatitis is also called chicken Campylobacter hepatitis. The pathogen is Campylobacter jejuni. The disease course is slow and the incidence is high. It can reduce egg production by 25-35%. Young chickens may delay egg production or low egg production. , the most obvious case change is hepatitis or hepatic necrosis. Although the mortality rate of this disease is low, it is easy to cause the body's resistance to decline, and it is easy to cause secondary infections such as E. coli and Salmonella, resulting in death.

[0003] Now the disease is more difficult to treat, and common medicines are used. While killing the pathogen, they often have no therapeutic effect on hepatitis. Similarly, they cannot kill the pathogen while treating hepatitis. In addition, the drug resistance of bacteria is more serious now. Antibacterial drugs can not control the disease very well, and the current breeders cannot reasonably cooperate or combine drugs, resulting in poor treatment effect and serious losses